Event Information

Medical device funding is on the rise. According to the Q209 MoneyTree report, medical device companies received $628M in 75 deals—a 39% increase from Q1. Medical device funding represented 17% of total VC funding, with life sciences (medical device + biotech) receiving 41%—an all time high.

Please join PricewaterhouseCoopers, Cooley Godward Kronish and a panel of experts as we discuss the current conditions and trends in this growing industry.

OUR DISCUSSION WILL INCLUDE:

·         Perspectives from the venture capital, analyst, and entrepreneurial communities on current conditions and trends in medical device funding

·         Predictions for growth within the sector

·         Challenges faced by medical device companies in the current environment

Mark Weeks – Partner, Cooley Godward Kronish LLP

PANELISTS

Robin Bellas – Partner, Morgenthaler
Rich Ferrari – Managing Director, De Novo Ventures
Tracy Lefteroff – Partner, PricewaterhouseCoopers LLP
Reza Zadno – Founder, CEO and President, Visiogen

WHO SHOULD ATTEND

By Invitation Only. Venture Capital companies, Chief Executive Officers, Chief Financial Officers, Chief Information Officers, Chief Operating Officers and General Counsel from medical device companies (public and private).

REGISTRATION REQUIRED. There is no cost to attend this session.